These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 38014966)
1. Elucidating the impact of bacterial lipases, human serum albumin, and FASII inhibition on the utilization of exogenous fatty acids by Pruitt EL; Zhang R; Ross DH; Ashford NK; Chen X; Alonzo F; Bush MF; Werth BJ; Xu L mSphere; 2023 Dec; 8(6):e0036823. PubMed ID: 38014966 [TBL] [Abstract][Full Text] [Related]
2. Elucidating the Impact of Bacterial Lipases, Human Serum Albumin, and FASII Inhibition on the Utilization of Exogenous Fatty Acids by Pruitt EL; Zhang R; Ross DH; Ashford NK; Chen X; Alonzo F; Bush MF; Werth BJ; Xu L bioRxiv; 2023 Jun; ():. PubMed ID: 37425828 [No Abstract] [Full Text] [Related]
7. Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus. Gloux K; Guillemet M; Soler C; Morvan C; Halpern D; Pourcel C; Vu Thien H; Lamberet G; Gruss A Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193654 [TBL] [Abstract][Full Text] [Related]
8. The Phospholipase A1 Activity of Glycerol Ester Hydrolase (Geh) Is Responsible for Extracellular 2-12( Subramanian C; Frank MW; Yun MK; Rock CO mSphere; 2023 Apr; 8(2):e0003123. PubMed ID: 36976028 [TBL] [Abstract][Full Text] [Related]
9. (p)ppGpp/GTP and Malonyl-CoA Modulate Staphylococcus aureus Adaptation to FASII Antibiotics and Provide a Basis for Synergistic Bi-Therapy. Pathania A; Anba-Mondoloni J; Gominet M; Halpern D; Dairou J; Dupont L; Lamberet G; Trieu-Cuot P; Gloux K; Gruss A mBio; 2021 Feb; 12(1):. PubMed ID: 33531402 [TBL] [Abstract][Full Text] [Related]
16. Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. Parsons JB; Frank MW; Subramanian C; Saenkham P; Rock CO Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15378-83. PubMed ID: 21876172 [TBL] [Abstract][Full Text] [Related]
17. Teoh WP; Chen X; Laczkovich I; Alonzo F Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753501 [TBL] [Abstract][Full Text] [Related]
18. Host Fatty Acid Utilization by Staphylococcus aureus at the Infection Site. Frank MW; Yao J; Batte JL; Gullett JM; Subramanian C; Rosch JW; Rock CO mBio; 2020 May; 11(3):. PubMed ID: 32430471 [No Abstract] [Full Text] [Related]
19. Growth-Environment Dependent Modulation of Staphylococcus aureus Branched-Chain to Straight-Chain Fatty Acid Ratio and Incorporation of Unsaturated Fatty Acids. Sen S; Sirobhushanam S; Johnson SR; Song Y; Tefft R; Gatto C; Wilkinson BJ PLoS One; 2016; 11(10):e0165300. PubMed ID: 27788193 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of the exogenous fatty acid utilization pathway leads to increased resistance to unsaturated fatty acids in Staphylococcus aureus. Krute CN; Ridder MJ; Seawell NA; Bose JL Microbiology (Reading); 2019 Feb; 165(2):197-207. PubMed ID: 30566075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]